|
Characteristics
|
HF patients (n = 9)
|
Non-HF patients (n = 8)
|
P
value
|
|---|
|
Men
|
6 (66.7%)
|
7 (87.5%)
|
0.576
|
|
Women
|
3 (33.3%)
|
1 (12.5%)
|
0.576
|
|
Age (years)
|
60.1 ± 14.3
|
51.8 ± 7.2
|
0.147
|
|
BMI (kg/m2)
|
26.8 ± 3.1
|
25.6 ± 1.6
|
0.323
|
|
Hypertension
|
3 (33.3%)
|
1 (12.5%)
|
0.576
|
|
Diabetes
|
2 (22.2%)
|
1 (12.5%)
|
>0.999
|
|
Previous MI
|
0 (0%)
|
0 (0%)
|
NA
|
|
Smoking
|
3 (33.3%)
|
5 (62.5%)
|
0.347
|
|
Hypercholesterolemia
|
5 (55.6%)
|
4 (50%)
|
>0.999
|
|
AMI
|
8 (88.9%)
|
3 (42.9%)
|
0.106
|
|
NT-proBNP (pg/mL)a
|
918.3 ± 848.5
|
62 ± 14.1
|
<0.001
|
|
LVEF (%)a
|
39.3 ± 8.4
|
66.8 ± 1.9
|
0.001
|
|
Medications
|
|
Aspirin
|
9 (100%)
|
8 (100%)
|
NA
|
|
Clopidogrel
|
8 (88.9%)
|
8 (100%)
|
>0.999
|
|
Beta blockers
|
9 (100%)
|
8 (100%)
|
NA
|
|
ACE inhibitors
|
9 (100%)
|
8 (100%)
|
NA
|
|
Statins
|
9 (100%)
|
8 (100%)
|
NA
|
|
Diuretics
|
7 (77.8%)
|
1 (12.5%)
|
0.015
|
-
aNT-proBNP, LVEF measured 6 months after AMI.
- Data are presented as mean value ± standard deviation or number or percentage of patients. P value <0.05 was considered significant.
- ACE, angiotensin-converting enzyme; AMI, anterior myocardial infarction; BMI, body mass index; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NA, not applicable; NT-proBNP, N-terminal pro-brain natriuretic peptide.
